Biomarkers & Hypersensitivity Pneumonitis Progression

Trial Objective

Biomarkers & Hypersensitivity Pneumonitis ProgressionResearchers are studying the blood of hypersensitivity pneumonitis (HP) patients to find out if biomarkers found can predict the progression of the disease. Researchers are particularly interested in understanding if the biomarkers in blood can predict the speed of disease progression.

Enrollment

Active Clinical Trials Currently Recruiting

Who Can Participate

Adults 18 years of age and older.

Age: 18-80    Gender: Any Gender


Estimated Time Commitment

5 total visits, each lasting 2-4 hours



Payment & Reimbursement  

Payment: Not Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Natassa Bourkas
303.398.1172 

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

National Institutes of Health

Principal Investigators

Co-Investigators


Request More Information

By completing this form, you agree to learn more about this study and see if you qualify.


*
*
*
*
 I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: